相似文献
1
Comparison of dantrolene sodium and diazepam in the treatment of spasticity.
J Neurol Neurosurg Psychiatry. 1976 Apr;39(4):350-6. doi: 10.1136/jnnp.39.4.350.
2
Treatment of spasticity in multiple sclerosis: comparison of dantrolene sodium and diazepam.
Trans Am Neurol Assoc. 1975;100:235-7.
3
A comparison of dantrolene sodium and diazepam in the treatment of spasticity.
Paraplegia. 1974 Nov;12(3):170-4. doi: 10.1038/sc.1974.27.
4
The effect of dantrolene sodium on spasticity in multiple sclerosis.
Neurology. 1973 Dec;23(12):1313-5. doi: 10.1212/wnl.23.12.1313.
5
Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.
Drugs. 1977 Jan;13(1):3-23. doi: 10.2165/00003495-197713010-00002.
6
[Clinical study of sodium dantroline (Dantrium) in multiple sclerosis (author's transl)].
Acta Neurol Belg. 1978 May-Jun;78(3):141-7.
7
Dantrolene sodium: long-term effects in severe spasticity.
Arch Phys Med Rehabil. 1973 Jul;54(7):311-5.
8
Dantrolene sodium for treatment of spasticity.
Med Lett Drugs Ther. 1974 Jul 19;16(15):61-2.
9
Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease.
Practitioner. 1978 Jul;221(1321):123-7.
10
Medical treatment for spasticity in children with cerebral palsy.
Childs Brain. 1976;2(5):304-8. doi: 10.1159/000119626.
引用本文的文献
1
Pain Management in Multiple Sclerosis: a Review of Available Treatment Options.
Curr Treat Options Neurol. 2019 Nov 27;21(12):62. doi: 10.1007/s11940-019-0601-2.
2
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.
Ther Adv Neurol Disord. 2011 May;4(3):139-68. doi: 10.1177/1756285611403646.
3
Motor Restoration and Spasticity Management after Stroke.
Curr Treat Options Neurol. 2002 Nov;4(6):427-433. doi: 10.1007/s11940-002-0010-8.
4
Evidence basis for treatment of spasticity.
Curr Neurol Neurosci Rep. 2001 Nov;1(6):501-6. doi: 10.1007/s11910-001-0051-5.
5
Anti-spasticity agents for multiple sclerosis.
Cochrane Database Syst Rev. 2000;2003(4):CD001332. doi: 10.1002/14651858.CD001332.
6
Pharmacological interventions for spasticity following spinal cord injury.
Cochrane Database Syst Rev. 2000;2000(2):CD001131. doi: 10.1002/14651858.CD001131.
7
Drugs used to treat spasticity.
Drugs. 2000 Mar;59(3):487-95. doi: 10.2165/00003495-200059030-00006.
8
Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
Drugs. 1986 Aug;32(2):130-68. doi: 10.2165/00003495-198632020-00003.
9
Relationship between plasma concentration and effect of dantrolene sodium in man.
Eur J Clin Pharmacol. 1979 Sep;16(3):203-9. doi: 10.1007/BF00562062.
10
Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.
Drugs. 1977 Jan;13(1):3-23. doi: 10.2165/00003495-197713010-00002.
本文引用的文献
1
Efficacy of dantrolene sodium in the treatment of spasticity.
Dis Nerv Syst. 1974 Sep;35(9):427-31.
2
QUANTITATIVE CLINICAL NEUROLOGICAL TESTING. I. A STUDY OF A BATTERY OF TESTS DESIGNED TO EVALUATE IN PART THE NEUROLOGICAL FUNCTION OF PATIENTS WITH MULTIPLE SCLEROSIS AND ITS USE IN A THERAPEUTIC TRIAL.
Ann N Y Acad Sci. 1965 Mar 31;122:480-505. doi: 10.1111/j.1749-6632.1965.tb20231.x.
3
FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS.
Neurology. 1965 Jul;15:654-61. doi: 10.1212/wnl.15.7.654.
4
QUANTITATIVE CLINICAL NEUROLOGICAL TESTING. II. SOME STATISTICAL CONSIDERATIONS OF A BATTERY OF TESTS.
J Chronic Dis. 1965 Mar;18:303-11. doi: 10.1016/0021-9681(65)90157-8.
5
An assessment of the reliability of three methods used in evaluating the status of multiple sclerosis patients.
J Chronic Dis. 1969 Apr;21(11):803-14. doi: 10.1016/0021-9681(69)90026-5.
6
Spasticity and its amelioration.
Mod Trends Neurol. 1970;5(0):41-59.
7
Oral diazepam in the treatment of spasticity in paraplegia a double-blind trial and subsequent impressions.
Scott Med J. 1966 Feb;11(2):46-51. doi: 10.1177/003693306601100202.
8
Long-term follow-up on the use of diazepam in the treatment of spasticity.
Am J Phys Med. 1968 Jun;47(3):143-9.
9
Drugs in the management of spasticity.
Dev Med Child Neurol. 1971 Jun;13(3):386-8. doi: 10.1111/j.1469-8749.1971.tb03278.x.
10
A double blind, cross-over trial of Valium in the treatment of spasticity.
Paraplegia. 1972 May;10(1):19-22. doi: 10.1038/sc.1972.4.
Zotero 插件